Osaic Holdings
HRTX icon

Osaic Holdings’s Heron Therapeutics HRTX Stock Holding History

Osaic Holdings’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$2K – 7051
2021
Q1 		$2K Buy
+15
New +$267 ﹤0.01% 6482

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Osaic Holdings's HRTX Position: Q2 2026 in Review

Osaic Holdings reduced its Heron Therapeutics (HRTX) stake by 78% in Q2 2026, selling an estimated $2.4K and leaving 861 shares worth $369. The position accounts for ﹤0.01% of the portfolio, ranked #7703.

Osaic Holdings first reported a position in HRTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $652K in Q2 2021. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Osaic Holdings held 861 shares of Heron Therapeutics worth $369 as of Q2 2026.
  • Osaic Holdings sold 3,000 Heron Therapeutics shares in Q2 2026, an estimated $2.4K.
  • Heron Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7703 holding.
  • Osaic Holdings first reported a position in Heron Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Heron Therapeutics position peaked at $652K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.